Thyroid Cancer
Hierarchy of treatment variables affecting outcome of 131I therapy listed
Published in Cancer Weekly, September 13th, 2005
In a recent report, researchers in Ukraine conducted a study "to assess the correlations between the first 131I activity value, time interval between the courses of radioiodine treatment and the overall number of courses required for total destruction of lung metastases in patients with differentiated thyroid cancer with metastatic lesions in lungs. Twenty seven patients with differentiated thyroid cancer with metastases in lungs have been treated with radioiodine after surgical intervention."
"Activities administered amounted from 1600...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-09-13)
More Articles from Cancer Weekly
- Carcinogenesis
Storage practices impacted acrylamide formation during potato frying - Neurofibroma
Soft tissue perineurioma clinicopathologically analyzed - Ovarian Cancer
Patients unlikely to benefit from further chemotherapy identified - Suicide
Prostate cancer deemed risk factor for late-life suicide - Acute Lymphoblastic Leukemia
Pediatric protocols yield better outcomes for young-adult ALL patients - Adenocarcinoma
Outcome of surgical treatment for early esophageal adenocarcinoma revealed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
